During initial development, both X chromosomes are active in females, and one of them must be silenced at the appropriate time in order to dosage compensate their gene expression levels to male counterparts. Silencing involves epigenetic mechanisms, including histone deacetylation. Major X chromosome inactivation (XCI) in bovine occurs between hatching and implantation, although in vitro culture conditions might disrupt the silencing process, increasing or decreasing X-linked gene expression. In this study, we aimed to address the roles of histone deacetylase inhibition by trichostatin A (TSA) on female preimplantation development. We tested the hypothesis that by enhancing histone acetylation, TSA would increase the percentage of embryos achieving 16-cell stage, reducing percentage of embryos blocked at 8-cell stage, and interfere with XCI in IVF embryos. We noticed that after TSA treatment, acetylation levels in individual blastomeres of 8-16 cell embryos were increased twofold on treated embryos, and the same was detected for blastocysts. Changes among blastomere levels within the same embryo were diminished on TSA group, as low-acetylated blastomeres were no longer detected. The percentage of embryos that reached the 5th cleavage cycle 118 h after IVF, analyzed by Hoechst staining, remained unaltered after TSA treatment. Then, we assessed XIST and G6PD expression in individual female bovine blastocysts by quantitative real-time PCR. Even though G6PD expression remained unaltered after TSA exposure, XIST expression was eightfold decreased, and we also detected a major decrease in the percentage of blastocysts expressing detectable XIST levels after TSA treatment. Based on these results, we conclude that HDAC is involved on XCI process in bovine embryos, and its inhibition might delay X chromosome silencing and attenuate aberrant XIST expression described for IVF embryos.
Introduction
Despite their phenotypic similarities, male and female embryos present some major differences regarding their preimplantation development pattern. Male embryos develop faster (Avery et al. 1992) and reach the blastocyst stage more frequently (Xu et al. 1992) , while female embryos are more sensitive to in vitro culture (IVC; Edwards et al. 2001) . Female IVF bovine blastocysts display lower cell numbers and increased apoptosis rates than their male counterparts (Oliveira et al. 2010) . Furthermore, the ratio of male:female blastocyst in some in vitro systems is lower than the expected 1:1 (Avery et al. 1992 , Lonergan et al. 1999 , Wrenzycki et al. 2002 . Also, abnormalities such as increased body weight at birth (Fernandez-Gonzalez et al. 2004 ) are described in mice especially for female embryos produced in vitro.
One of the main molecular differences between male and female embryos during preimplantation development is the double expression levels of X-linked genes, as at the beginning of development, female embryos still present two active X chromosomes. One of them must be inactivated at the appropriate time for further development, a phenomenon known as dosage compensation, which takes place in the inner cell mass at the blastocyst stage in mouse (reviewed by Augui et al. (2011) ). At the onset of this process, one X chromosome is coated by the upregulated XIST transcript, followed by asynchronous replication timing, and finally chromatin modifications set the stable inactive and condensed chromatin state (reviewed by Augui et al. (2011) ). In mouse, paternal X chromosome undergoes imprinted inactivation from cleavage stages, and reactivation occurs in cells of the inner cell mass, in which random X inactivation occurs (Mak et al. 2004 , Okamoto et al. 2004 . Recent studies suggest that silencing of X chromosome might be initiated in the absent of XIST, but XIST RNA is required for imprinted X chromosome inactivation (XCI) and stabilization of silencing (Kalantry et al. 2009 ). XIST dependence for XCI appears to be stronger at genes that had acquired dosage compensation for longer time during evolution.
In previous studies, we demonstrated that HDAC inhibition by trichostatin A (TSA) has distinct effects between male and female blastocysts and that the increased acetylation levels did not affect blastocyst rates or cell numbers (Oliveira et al. 2010) . In this study, we aimed to further investigate the effects of HDAC inhibition on female development. It is known that HDAC plays a role in XCI, promoting deacetylation of the coding regions of X-linked genes and of the upstream region of XIST (O'Neill et al. 1999) . O'Neill et al. (1999) showed that in murine ES cells, TSA prevents XCI, and the subsequent removal of the inhibitor leads to normal XCI.
Gene expression profiles comparing male and female embryos suggest that in bovine, XCI occurs between days 7 and 14 (Bermejo-Alvarez et al. 2011). However, XCI-related mechanisms can be initiated in vitro as early as at the 2-cell stage, when low XIST expression can be detected, even though late replication can only be detected at early blastocyst stage (De La Fuente et al. 1999) . In addition, when the expression pattern of X-linked genes displayed by in vitro-produced (IVP) embryos is compared with their in vivo counterparts, higher levels of XIST expression are detected on IVP embryos (Wrenzycki et al. 2002 , Nino-Soto et al. 2007 . Those results suggest that mechanisms regulating XCI are affected by IVC.
Therefore, the objective of this study was to investigate the effects of TSA on acetylation levels of individual blastomeres of female IVP bovine embryos just after embryonic genome activation (8-to 16-cell stage) and in blastocysts, and their effects on cell cycle progression and expression of X-linked genes. We tested the hypothesis that TSA would increase histone acetylation levels, affecting XCI-related events during IVC.
Results

Standardization of X-sorted semen for IVF experiments
Even though flow cytometer sperm sorting is well established (Seidel et al. 1999 , Hamano 2007 , we validated in our system for IVP of blastocysts. Briefly, 53 blastocysts from two replicates produced using X-bearing spermatozoa from the same bull were sexed using conventional PCR, and we detected 98.10% of female embryos. Therefore, we concluded that straws from Lagoa da Serra (Sertaozinho, Brazil) were adequate for performing experiments with female embryos.
TSA treatment did not affect blastocyst development rate of female embryos
We detected similar developmental rates for female embryos treated with 5 nM TSA and control (nZ113 cleaved embryos, 55-58 per group, obtained in three replicates. Blastocyst development (number/rate): control, 24/43.64% and TSA, 21/36.21%). In previous studies, we standardized 5 nM concentration as being the less harmful tested for bovine embryos, considering apoptosis, cell number, and blastocyst rates (Oliveira et al. 2010 (Oliveira et al. , 2011 .
TSA treatment did not affect cleavage progression of female embryos
We evaluated cleavage progression on female TSA-treated embryos compared with control group. Five replicates and a total of 641 cleaved embryos (nZ307-334 per group; Table 1) were considered. In both groups, we saw a higher percentage of embryos classified at the 2nd and 4th cleavage cycle, followed by a lower (P!0.05) percentage distributed in the 3rd cleavage cycle and the lowest (P!0.05) percentage classified at the 5th cycle.
Therefore, considering that in bovine embryonic genome activation (EGA) occurs at the transition from the 4th to the 5th cleavage cycle, in our system, w37% of embryos 118 h.p.i. are distributed in EGA cleavage cycle or after. No difference was detected between TSA and control groups, regarding distribution between cleavage cycles. In conclusion, TSA did not affect cleavage cycle progression of female bovine embryos ranging from 2 to 32 cells.
TSA enhances levels of H3k9ac on blastomeres from female 9-16 cell embryos
We assessed twelve 9-16 cell embryos (nZ6 per group), totaling 156 blastomeres (nZ77-79 per group) divided into two replicates.
Mean fluorescence values of TSA group blastomeres were 2.21-fold higher (P!0.05) than control group blastomeres ( Fig. 1I and II) .
Besides the higher average acetylation levels, we noticed that H3k9ac levels of individual blastomeres within the same embryo were similar within each TSA-treated embryo. On the other hand, for control group embryos, we found a high variation of H3k9ac levels among individual blastomeres. To analyze this difference, we normalized the blastomere acetylation levels on each embryo considering the lowest blastomere level. Therefore, we saw that in TSA-treated embryos, levels were ranging from 1-to a maximum of 2.41-fold difference within blastomeres from the same embryo (Fig. 1III) . On control group, a wider distribution was found, and levels of acetylation reached 5.92-fold higher.
On control group, we detected five classes of blastomeres (Fig. 1III) , and the highest percentage of blastomeres (59.24%) was classified in one-to twofold difference. Classes two-to threefold and three-to fourfold presented 22.22% and 10.35% of blastomeres respectively without displaying significant difference from none other class. Classes four-to fivefold and five-to sixfold showed similar percentages (8.18% and 5.41% respectively), both of them lower (P!0.05) than classes one-to twofold percentage. For TSA-treated embryos, only two classes of blastomeres were found (one-to twofold and two-to threefold), and no difference was detected among them (63.26 and 36.73% respectively). These results indicate that TSA increases blastomere levels and leads to a homogeneous distribution of H3k9ac modification between blastomeres within each embryo, apparently by particularly increasing levels of low acetylated blastomeres.
TSA increases levels of H3k9ac on both ICM and TE of female blastocysts
Then, we analyzed levels of acetylation in female blastocysts developed into TSA-supplemented medium. We evaluated 12 blastocysts (nZ5-7 per group), separately for ICM and TE cells.
We saw that ICM and TE levels of acetylation were similar within groups (Fig. 2) . TSA treatment increased (P!0.05) ICM and TE levels in the same manner.
Based on these results, we concluded that ICM and TE cells similarly responded to TSA treatment, by increasing their acetylation levels w2.35-fold compared with control group.
XIST expression was decreased in TSA-treated blastocysts
Then we evaluated the effects of TSA on expression of X chromosome genes XIST and G6PD. As we expected high variability of XIST expression among embryos, we decided to assess individual gene expression instead of embryo pool analysis, aiming not to mask distinct profiles. We assessed 19 individual female blastocysts (nZ9-10 per group). We detected that preamplification efficiency of specific cDNA before gene expression analysis showed a high correlation (rZ0.9109) of cDNA quantity between samples and a high correlation (P!0.05) between gene expression measurements (XIST, rZ0.9277 and G6PD, rZ0.9107) of samples before and after preamplification for the validated genes (Saraiva et al. 2012) . Therefore, preamplification system was suitable for our experiments. Relative levels of G6PD mRNA remained unaltered between control and TSA-treated blastocysts (Fig. 3I) . However, relative levels of XIST were 8.12-fold higher (P!0.05) on control compared with TSA-treated blastocysts (Fig. 3II ). When we assessed relative levels of XIST for individual blastocysts ( Fig. 3III and IV) , we noticed that only one blastocyst (10%) did not exhibit detectable XIST expression in control group, against 4 (44.4%) in TSA-treated group. Besides, levels of TSA-treated blastocysts that exhibited XIST expression were much lower than control group levels. Therefore, TSA treatment did not affect G6PD expression but decreased XIST expression in bovine blastocysts.
Discussion
This study provides data regarding the effect of TSA supplementation on female bovine preimplantation development. Our main findings are that I) TSA did not improve the percentage of embryos that reached 5th cell cycle, II) histone acetylation induced by TSA equalized blastomere levels, increasing especially levels of low acetylated cells, and III) HDAC inhibition decreased XIST expression in treated blastocysts, a fact that might delay XCI and consequently affect postimplantation development of those embryos.
XCI is an essential process of embryonic development that occurs in order to dosage compensate the expression of female genes to their male counterparts. In this process, XIST RNA is upregulated and coats one X chromosome. XIST creates a transcriptionally silent nuclear compartment and induces gene repression by A-repeat-dependent mechanism (Chaumeil et al. 2006) . XIST also appears to have a role in shaping the conformation of the inactive X chromosome (Splinter et al. 2011) .
In bovine, studies have shown that a percentage of IVP embryos present at least one blastomere exhibiting late replication during preimplantation development, at rates that varies from 28% in early blastocysts to 77% after hatching (De La Fuente et al. 1999) . However, recent studies based on gene expression profile of male and female embryos suggest that dosage compensation occurs in bovine at some stage between hatching and implantation, which is inferred based on the presence of approximately a double amount of X-linked genes, including G6PD, at day 7, and the same amount at day 14, comparing male and female counterparts (Bermejo-Alvarez et al. 2011) .
It is known that IVC interferes with expression of X-linked genes. Controversial results were found regarding G6PD expression, which was shown to be increased in some studies (Gutiérrez-Adán et al. 2000 , Peippo et al. 2002 , Wrenzycki et al. 2002 , Lopes et al. 2007 , Morton et al. 2007 , Bermejo-Alvarez et al. 2011 and decreased in others (Merighe et al. 2009 ), when comparing female and male IVP blastocysts. Considering that G6PD varies its expression according to respiration and metabolism (Lopes et al. 2007) , their different mRNA levels among systems might be related to stressful culture conditions. However, G6PD variations in the same system might regard to disruptions on the XCI process, as G6PD suffers dosage compensation after XCI in bovine (Basrur et al. 2004) . Some authors describe X-linked expression in IVP blastocyst as aberrant, including higher levels of XIST expression (Wrenzycki et al. 2002, Nino-Soto Means with different letters are not equal (ANOVA one-way and Tukey's posttest, P!0.05). Data from two replicates and 12 blastocysts (nZ5-7 per group) obtained 7 days after IVF. et al. 2007). Our group found that only 23% of in vivo-produced blastocysts presented detectable XIST expression, against 80% of IVP blastocysts (Saraiva et al. 2012) . Therefore, we think that as XCI is supposed to occur during the elongation phase, slower female development and loss of pregnancy could be related to a premature XCI caused by IVC conditions (personal observation). Here, we described that XIST expression was downregulated eightfold in TSA-treated embryos. This result agrees with the fact that deacetylation of coding regions of X-related genes and of the upstream promoter of XIST is essential for XCI, and HDAC inhibition prevents this and other XCI-related events, including XIST upregulation (O'Neill et al. 1999) . In this case, TSA might have prevented deacetylation of XIST promoter and also its upregulation, which in control group was already occurring.
Recently, Matoba et al. (2011) described XIST inactivation by RNAi in reconstructed oocytes as an efficient strategy for improving development of female clones in mice. The authors argued that aberrant expression of XIST is one of the main disruptive mechanisms in nuclear reprogramming and suggest that the fate of cloned embryos is determined almost exclusively before implantation by their XCI status. Therefore, TSA supplementation might be an interesting approach aiming decreased XIST expression in clones, and this strategy might improve postimplantation development also for IVF embryos. Additionally, we detected that G6PD expression remained unaltered after HDAC inhibition. Although histone deacetylation has a fundamental role in regulating gene expression, HDAC inhibitors seem to directly affect transcription of only 2-10% of genes (Johnstone 2002) . Therefore, TSA did not directly affect G6PD expression. Even though XIST coating initiates XCI process, X-linked gene transcription does not seem to be coupled, as during reactivation of paternal X in inner cell mass, cell transcription precedes loss of XIST coating in mice (Williams et al. 2011) .
It might be the case that XCI was not achieved in control embryos neither in TSA-treated embryos, and the process at this developmental stage was only initiating. However, this certainly would have effects on implantation. XIST inhibition caused by TSA might retrieve their levels closer to in vivo-produced embryos. We think that this delay in the initiation of XCI process might be beneficial for IVP embryos and help their implantation and further development.
Apparently, TSA increased acetylation levels of 8-16 cell embryos especially on low acetylated blastomeres. In control group, we detected a remarkable difference between acetylation levels of blastomeres within the same embryo. This effect is not likely to be related to cell cycle, as increased H3k9ac levels can be observed both in interphase and in cells entering metaphase (Fig. 2) . In treated group, blastomeres presented similar levels within the same embryo. Therefore, in TSA-treated embryos, levels of H3k9ac were equalized, and average levels increased 2.2-fold. As deacetylation of X genes occurs at the onset of XCI process (O'Neill et al. 1999) , those low acetylated blastomeres found in control group might be more susceptible to XCI and XIST upregulation. Studies have revealed that TSA induces cell cycle arrest and apoptosis, by activating the expression of proapoptotic genes (Yakovlev et al. 2010) and by opening chromatin structure, which becomes more susceptible to endonucleases (Koyama et al. 2000) . We have previously reported that 5 nM TSA did not affect blastocyst cell number and apoptosis on female embryos (Oliveira et al. 2010) . Here, we confirmed that TSA supplementation did not affect cleavage cycle progression of female blastocysts. However, in this concentration, no beneficial effect was observed on percentage of embryos blocked at 8-cell stage, as we hypothesized on previous studies.
In conclusion, our results show that HDAC inhibition using low TSA concentration has no effect over cleavage cycle progression and increases histone acetylation levels of female embryos, especially on low acetylated blastomeres. Based on our data, we conclude that XIST expression in bovine is related to HDAC and that HDAC inhibition decreases XIST mRNA levels. Whether or not decreased XIST expression levels are beneficial to postimplantation development remains to be elucidated.
Materials and Methods
Supplements
Reagents and culture media were purchased from Sigma Chemical Co. unless otherwise stated.
Preparation and selection of oocytes
Bovine ovaries from Bos Taurus!Bos Indicus crossbred were collected at a local slaughterhouse and processed within 2 h after killing. The ovaries were washed in saline (37 8C) and follicles measuring 3-8 mm in diameter were aspirated with an 18-gauge needle coupled to a 20 ml syringe. Cumulus-oocyte complexes (COCs) presenting at least three layers of cumulus cells and homogenous cytoplasm were selected under a stereomicroscope. The COCs were washed in HEPES-buffered TCM-199 (Gibco BRL) supplemented with 10% fetal bovine serum (FBS; Cripion, Andradina, Brazil), 16 mg/ml sodium pyruvate, and 83.4 mg/ml amikacin (Instituto Biochimico, Rio de Janeiro, Brazil).
In vitro maturation
Groups of 15 COCs were transferred to 100 ml drops of medium containing sodium bicarbonate-buffered TCM-199 supplemented with 10% FBS, 1.0 mg/ml FSH (Folltropin, Bioniche Animal Health, Belleville, ON, Canada), 50 mg/ml human chorionic gonadotrophin (Profasi, Serono), 1.0 mg/ml estradiol, 16 mg/ml sodium pyruvate, and 83.4 mg/ml amikacin covered with sterile mineral oil (Dow Corning Co., Midland, MI, USA) and incubated for 24 h at 38.5 8C in an atmosphere of 5% CO 2 in air under saturated humidity.
IVF
After in vitro maturation, the cumulus cells were partially removed from the oocytes by pipetting. Groups of 25 oocytes were washed twice and transferred to 30 ml drops of TALP-IVF medium supplemented with 0.6% BSA, 10 mg/ml heparin, 18 mM penicillamine, 10 mM hypotaurine, and 1.8 mM epinephrine and covered with sterile mineral oil. Frozen straws of semen from the same bull sexed for X-chromosome bearing spermatozoa by flow cytometry (Lagoa da Serra, Sertãozinho, Brazil) were used. Flow cytometric sperm sorting based on differences in their DNA content is the best method for separation of X-and Y-chromosome bearing spermatozoa, and its accuracy is about 90% (Seidel et al. 1999 , Hamano 2007 . Each straw containing w2 million spermatozoa was centrifuged separately on a discontinuous 45/90 Percoll gradient for 7 min at 3600 g. The pellet was resuspended in 700 ml TALP-IVF medium and again centrifuged for 5 min at 520 g. After centrifugation, 80 ml of the medium containing the pellet was collected from the bottom of the tube and homogenized in a conic tube. The final suspension was divided among five oocytecontaining drops, in a final concentration of w10 4 spermatozoa for each oocyte. The plates were incubated at 38.5 8C for 20 h in an atmosphere of 5% CO 2 in air under saturated humidity.
We also evaluated the sex of blastocysts produced with X-bearing spermatozoa in our system by conventional PCR. 
In vitro culture
After IVF, presumptive zygotes were partially denuded of cumulus cells by vigorous pipetting and cultured in SOF medium supplemented with 2.5% FBS and 5 mg/ml BSA at 38.5 8C in an atmosphere of 5% CO 2 in air under saturated humidity. Groups of 15-20 presumptive zygotes were cultured in 100 ml drops. The embryos were washed and transferred to 100 ml drops of IVC medium supplemented with 0 nM (control) and 5 nM TSA 70 h after IVF and remained in TSA-supplemented medium until collection (day 5 embryos or blastocysts).
TSA was diluted at a concentration of 3.3 mM in ethanol and diluted to a final concentration of 5 nM in SOF medium.
Cell cycle evaluation
Embryos 48 h after TSA supplementation were collected (118 h post-IVF). First, hyaluronidase was used to remove any remaining cumulus cells. Then, every structure was fixed with 4% formaldehyde for 20 min at 37 8C and stained with Hoechst 33342 for 15 min. The embryos were washed in PBS and examined under a fluorescence microscope. Each structure was classified regarding their cleavage cycle (2nd, 3rd, 4th, and 5th).
Immunocytochemistry of H3K9ac
After 48 h of treatment with TSA, embryos (118 h post-IVF) were fixed in 4% paraformaldehyde for 30 min at 37 8C and stored at 4 8C in PBS supplemented with 3% BSA and 0.5% Triton X-100 for up to 1 week. Blastocysts were fixed by the same procedure 7 days after IVF. The fixed embryos were incubated with blocking solution (3% BSA and 0.2% Tween 20 in PBS) for 1 h at room temperature. Next, embryos were incubated with the primary antibody (mouse anti-H3K9ac MAB, 1:100) for 12 h at 4 8C. The embryos were then washed three times in PBS for 10 min and incubated with the secondary antibody (CY3-conjugated sheep anti-mouse antibody, 1:200 for 8-16 cell embryos; and Alexa 488-chicken antimouse,1:200 for blastocysts (Alexa Fluor, Invitrogen, Carlsbad, CA, USA)) for 2 h. The nuclei were stained with 10 ml/ml Hoechst 33342 for 10 min. The embryos were washed three times for 10 min in PBS and examined under a fluorescence microscope. Reactions in which the primary antibody was omitted served as negative control. Images of each structure were captured with an AxioCam camera and stored using the AxioVision 4.7.1 Software (Carl Zeiss, Jena, Germany).
Images were measured for fluorescence intensity on each blastomere (day 5 embryos) and on ICM and TE separately (blastocysts) using Adobe Photoshop CS3 (Adobe Systems, Inc.). First, the two images from each embryo (Hoechst and CY3 or Alexa 488) were placed together in a new file, in different layers. For blastocyst images, inner cell mass region was removed and placed in another file, using the elliptical marquee tool. Nuclei were selected with the magic wand tool in Hoechst layer for each blastomere (day 5 embryos) or for all nuclei area (ICM and TE files). Sections were measured using the histogram function through the red or green channel, according to secondary antibody. Background levels were measured for each image and subtracted from nuclei levels. Photoshop assigns intensity values between 0 and 255 to each pixel in the selected area and then averages these intensities, giving the mean intensity of the selected section.
On day 5 embryos, we analyzed each embryo separately. Histogram function for each blastomere was recorded and background level was subtracted. Then, we selected the lower blastomere level for normalization (the normalizing blastomere). For that, each blastomere level was divided by the normalizing blastomere, and as a result, in each embryo values started from 1 onward (homogeneous embryos had levels around 1, and heterogeneous embryos had levels ranging from 1 to 4.5). This procedure was performed to allow comparison between embryos. Then, the degree of reactivity was classified into five categories, regarding the normalized intensity value. Categories 1-2 corresponded to blastomeres displaying low variation (one-to twofold) on H3k9ac levels compared with the normalizing blastomere; categories 5 and 6 corresponded to blastomeres displaying high variation (five-to sixfold) on H3k9ac levels compared with the normalized blastomere.
Real-time quantitative PCR
The preamplification of cDNA targets was necessary due to the small amount of mRNA obtained from each embryo. We used for preamplification the system validated by Mengual et al. (2008) , and we also performed a separate experiment in our laboratory to compare the correlation of cDNA quantity (Nanodrop; Thermo Scientific, Waltham, MA, USA) and gene expression data (DCT) between non-preamplified and preamplified samples (Saraiva et al. 2012) . For real-time quantitative PCR (RT-qPCR), individual day 7 blastocysts were placed in 0.2 ml PCR tubes with 2 ml PBS containing RNAse Out (Invitrogen) 4:1, frozen in liquid nitrogen, and stored at K80 8C. Total RNA was obtained from individual blastocysts with the RNeasy Micro kit (Qiagen). cDNA was synthesized using ImProm-II RT System (Promega) according to the manufacturer's instructions. The cDNA from each embryo was preamplified using TaqMan PreAmp Master Mix (Applied Biosystems) with 45 nM of the following primers: GAPDH (NM_001034034, 76 bp) F: 5 0 -AAGGCCATCA-CCATCTTCCA-3 0 , R: 5 0 -CCACTACATACTCAGCACCAGCAT-3 0 ; XIST (NR_001464, 99 bp) F: 5 0 -TTGGCTTTTAGATTAATTT-GATGAACAGCAT-3 0 , R: 5 0 -CCCTTTAGACTAGGCCCATTTCA-TA-3 0 ; and G6PD (XM_583628, 58 bp) F: 5 0 -GCCGTCCTC-TATGTGGAAAATGA-3 0 , R: 5 0 -CGCAGCGCAGGATGAAG-3 0 . Preamplification conditions were 95 8C 10 min, followed by 14 cycles of 95 8C 15 s, 57 8C for 45 s, and 72 8C for 4 min. Amplified cDNA was diluted 1:4. GAPDH was used as an internal housekeeping control. RT-qPCR was performed using the Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems). Amplifications were carried out in a final reaction volume of 20 ml containing SYBR Green master mix (Applied Biosystems), 2 ml cDNA template and 6 pmol primers. PCR conditions were 50 8C for 2 min and 95 8C for 10 min, followed by 40 cycles of 95 8C for 15 s, 60 8C for 30 s, and 72 8C for 40 s. The melting curves were acquired after PCR amplification confirming the specificity of the amplified products. Results were analyzed as G6PD and XIST gene expression relative to the housekeeping gene expression using a standard curve (Larionov et al. 2005) . Standard curve of each gene (G6PD, XIST, and GAPDH) was prepared by purifying the product of RT-qPCR reactions using QIAquick PCR Purification Kit (Qiagen). Dilutions ranged from 1 to 1:10 000, totaling five points.
Statistical analysis
Differences in fluorescence intensity in blastomeres from control and treated embryos were compared using unpaired t-test. Mean frequency of each category of normalized blastomeres and fluorescence intensity in inner cell mass and TE were analyzed by one-way ANOVA and means were compared by the Tukey's test. Blastocyst rates and distribution of control and TSA-treated embryos in respect to their cellular cycles were analyzed by the c 2 test. Relative expression levels of G6PD and XIST were compared by Mann-Whitney TSA affects XCI on IVF bovine blastocysts nonparametric test. All analysis were carried out using SAS 9.1 Software (SAS Institute, Inc., NC, USA), with a 5% level of significance.
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